Munshi Amit 4
4 · Inhibikase Therapeutics, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Munshi Amit
Director
Transactions
- Disposition to Issuer
Common Stock
[F1]2026-02-21−19,089→ 38,176 total
Holdings
- 365,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]As previously reported on a Form 4 filed on August 28, 2025, the Reporting Person received shares of Issuer common stock as merger consideration upon the completion of the acquisition of CorHepta Pharmaceuticals, Inc. on February 21, 2025 (the "Closing Date"), with 19,089 shares subject to forfeiture if a certain milestone is not achieved by the first anniversary of the Closing Date. On February 21, 2026, it was determined that such milestone was not achieved, resulting in the forfeiture of all 19,089 shares. The Reporting Person received no consideration from the Issuer in connection with such forfeiture.
Signature
/s/ Mark Iwicki, attorney-in-fact|2026-02-24